Stocksigma LogoStocksigma Logo

Dr. Lal PathLabs Completes 80% Stake Acquisition in Sunshine Healthcare Ghana

Dr. Lal PathLabs Limited announced that its wholly-owned subsidiary, Dr Lal PathLabs FZCO, Dubai, has completed the acquisition of an 80% stake in

Dr. Lal PathLabs Completes 80% Stake Acquisition in Sunshine Healthcare Ghana

Dr. Lal PathLabs Ltd 路 Others (Uncategorized) 路 26 Sept 2026, 10:25 pm

Dr. Lal PathLabs Completes 80% Stake Acquisition in Sunshine Healthcare Ghana Dr. Lal PathLabs Limited announced that its wholly-owned subsidiary, Dr Lal PathLabs FZCO, Dubai, has completed the acquisition of an 80% stake in Ghana-based Sunshine Healthcare Limited (SHL). Following the transaction, originally approved on 24th Jul'26 and completed on 26th Sep'26 in compliance with local Ghanaian regulations, SHL has officially become a step-down subsidiary of the company, expanding its international healthcare footprint.

Original exchange filing (PDF)

More announcements from Dr. Lal PathLabs Ltd

  • Attached 路 11 Nov 2026
  • Attached 路 10 Nov 2026
  • Attached 路 05 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Attached 路 04 Nov 2026
  • Dr. Lal Path Labs Ltd. has informed the Exchange regarding Appointment of Ms Vasuta Agarwal as Additional Director designated as Non- Executive Independent Director of the company w.e.f. November 04, 2026. 路 04 Nov 2026
  • Attached 路 04 Nov 2026

All Dr. Lal PathLabs Ltd announcements